United Therapeutics Imposes Limits on 340B Contract Pharmacy Pricing

 

BREAKING: Developments in 340B Contract Pharmacy Lawsuit

Ryan White Clinics for 340B Access (RWC-340B) late yesterday asked a federal district court to issue a temporary restraining order (TRO) and preliminary injunction requiring U.S. Health and Human Services (HHS) Secretary Alex Azar to issue 340B program binding administrative dispute resolution regulations within 60 days, requiring Azar to declare that federal law entitles covered entities to buy covered outpatient drugs at 340B discounts, and ordering Azar to enforce covered entities’ right to 340B discounts for contract pharmacy orders. (RWC-340B amended complaint and memo in support of motion for TRO). RWC-340B’s court filings come on the heels of drug manufacturers’ Eli Lilly’s and Sanofi’s motions to be allowed to participate in RWC-340B’s lawsuit against HHS, stemming from Lilly, Sanofi, and two other manufacturers’ denials of 340B pricing on drugs dispensed by contract pharmacies (see story below). We will report on this late-breaking news in an extra edition later today.

Subscribe now

.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report